Another lay off coming to CV

[anonymous]

Novartis will sell off Leqvio and take a loss. You heard it here first. Bye bye

 

[anonymous]

Novartis will sell off Leqvio and take a loss. You heard it here first. Bye bye

STFU! No one is going to buy this drug-not even if it’s 50 cents on the dollar. Novartis spent 10b….no one will pay 5b.

 

[anonymous]

STFU! No one is going to buy this drug-not even if it’s 50 cents on the dollar. Novartis spent 10b….no one will pay 5b.

At least not yet. Why not let the slapdicks run it even further into the ground and diminish its value even further?
Maybe they'll try something fresh and innovative like FTO-2 and give away even more syringes for free.
When it becomes a severely damaged asset another company could purchase it for pennies on the dollar.
I hope this happens, because Leqvio deserves far better than it has been given, and it would be nice to see competent professionals take a shot at it.

 

[anonymous]

At least not yet. Why not let the slapdicks run it even further into the ground and diminish its value even further?
Maybe they'll try something fresh and innovative like FTO-2 and give away even more syringes for free.
When it becomes a severely damaged asset another company could purchase it for pennies on the dollar.
I hope this happens, because Leqvio deserves far better than it has been given, and it would be nice to see competent professionals take a shot at it.

Uh, they have implemented FTO-2 basically, we’re sampling.

 

[anonymous]

Uh, they have implemented FTO-2 basically, we’re sampling.

But we aren’t getting sales credit for it, so no one is really sampling.

 

[anonymous]

But we aren’t getting sales credit for it, so no one is really sampling.

This should tell you everything about the fto program was a crock of shit.

The fto program was a pain in the ass for the office yet we still sent in a million syringes because reps got paid. The current sample program is easy for offices and no rep is utilizing. A full investigation is needed.